M, P., S, B., & LR, B. (2025). Apparent Nonresponse to PCSK9 Inhibition in a Patient With Heterozygous Familial Hypercholesterolemia Due to PCSK9 Gene Duplication. JACC. Case reports, 30(18), 103953. https://doi.org/10.1016/j.jaccas.2025.103953
Chicago Style (17th ed.) CitationM, Pindwarawala, Bose S, and Brunham LR. "Apparent Nonresponse to PCSK9 Inhibition in a Patient With Heterozygous Familial Hypercholesterolemia Due to PCSK9 Gene Duplication." JACC. Case Reports 30, no. 18 (2025): 103953. https://doi.org/10.1016/j.jaccas.2025.103953.
MLA (9th ed.) CitationM, Pindwarawala, et al. "Apparent Nonresponse to PCSK9 Inhibition in a Patient With Heterozygous Familial Hypercholesterolemia Due to PCSK9 Gene Duplication." JACC. Case Reports, vol. 30, no. 18, 2025, p. 103953, https://doi.org/10.1016/j.jaccas.2025.103953.